Login to Your Account



PharmaFocus

Baxter Ventures to Boost Pipeline, Not Bottom Line

By Marie Powers
Staff Writer

Friday, July 6, 2012

Baxter Ventures, the $200 million venture fund launched in July 2011 by Baxter International Inc., is on target to complete its first year with three equity investments and expects to close one or two more by the end of 2012, putting the fund on track to commit its first $50 million, including average initial investments of $1 million to $5 million plus potential follow-on funding.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription